Overview

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study investigated the efficacy of inhaled TOBI treatment for early infections of P. aeruginosa in paediatric patients with cystic fibrosis.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Pharmaceutical Solutions
Tobramycin